홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.1
  1. 홈
  2. /반응

Indomethacin → 5-Hydroxyicosa-6,8,11,14-tetraenoic acid

HRID 745511
인쇄

반응식

HRID 745511 반응식
N[C@@H:2]([CH2:6][CH2:7][C:8](N[C@H](C(NCC(O)=O)=O)CS)=[O:9])[C:3]([OH:5])=[O:4].[Cl-].[Cl-].[Ca+2].CC1N(C(C2C=CC(Cl)=CC=2)=O)[C:32]2[CH:31]=[CH:30][C:29](OC)=[CH:28][C:27]=2[C:26]=1[CH2:45][C:46](O)=O.C(N([CH2:65][C:66](O)=O)CC(O)=O)CN(CC(O)=O)CC(O)=O>CS(C)=O.C(O)C(N)(CO)CO.Cl>[CH3:3][CH2:2][CH2:6][CH2:7][CH2:65][CH:66]=[CH:46][CH2:45][CH:26]=[CH:27][CH2:28][CH:29]=[CH:30][CH:31]=[CH:32][CH:8]([OH:9])[CH2:7][CH2:6][CH2:2][C:3]([OH:5])=[O:4]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

7

반응물 4

HCID 3715IndomethacinHCID 6049Ethylenediaminetetraacetic AcidHCID 124886GlutathioneHCID 5284359Calcium Chloride

생성물 1

HCID 17715-Hydroxyicosa-6,8,11,14-tetraenoic acid

시약·촉매·용매 2

HCID 679Dimethyl Sulfoxide용매
HCID 93573
Tromethamine hydrochloride
용매

실험 절차

For enzyme assay, 100-200 μl of enzyme was incubated in the presence and absence of test compound (prepared in DMSO) for 10 minutes at 30° C. in 0.05M Tris-HCl buffer (pH 7.2) containing 1 mM glutathione, 2 mM CaCl2, 14 μM indomethacin and 0.25 and 0.5 mM EDTA (final volume 400 μl). The final DMSO concentration in these assays was 4%. The assay was initiated by the addition of 100 μl 14C-arachidonic acid (58 mCi/mmole) and incubations were carried out for 10 minutes at 37° C. in a shaking water bath. The reactions were stopped by the simultaneous addition of 4.0 ml of diethylether and 100 μl of 1.0 m citric acid, while the tubes were vigorously vortexed. The 14C-5-HETE generated by the enzyme was extracted into the acidified ether layer which was separated from the aqueous layer by freezing the assay tubes in a dry ice/acetone bath prior to decanting the liquid ether layer. The ether layer was evaporated to dryness under N2, the residue dissolved in 65 μl chloroform:methanol (2:1 v/v), prior to separating 14C-5-HETE from other 14C-labeled compounds on silica gel impregnated glass fiber TLC plates utilizing an elution solvent of isoctane:methylethylketone:acetic acid (100:9:1 v/v). 14C-5-HETE was identified by its co-chromatography with a chemically synthesized standard. The radioactive peaks of the chromatogram were cut out and the radioactivity was quantitated by liquid scintillation counting. The amount of 5-HETE obtained per sample was expressed as the percent of total and was calculated in the basis of: ##EQU2## in order to evaluate the effect of the test compounds, the mean percent inhibition of 14C-5-HETE production was calculated. The IC50 for a drug was determined from a linear regression analysis of a plot of the mean percent inhibition vs drug concentration.

후처리

  1. concentrationThe final DMSO concentration in these
  2. additionThe assay was initiated by the addition of 100 μl 14C-arachidonic acid (58 mCi/mmole) and incubations
  3. additionThe reactions were stopped by the simultaneous addition of 4.0 ml of diethylether and 100 μl of 1.0 m citric acid, while the tubes
  4. extractionwas extracted into the acidified ether layer which
  5. customwas separated from the aqueous layer
  6. customto decanting the liquid ether layer
  7. customThe ether layer was evaporated to dryness under N2
  8. dissolutionthe residue dissolved in 65 μl chloroform:methanol (2:1 v/v)
  9. customto separating 14C-5-HETE from other 14C-

출처 및 근거

ORD 기록
ord-c1879de4bd19431f973346720b231280
출처 데이터셋
uspto-grants-1986_07
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US04599336

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트